BIOLINERX LTD's ticker is BLRXXXXX and the CUSIP is 09071M106. A total of 25 filers reported holding BIOLINERX LTD in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $20,000 | +11.1% | 17,800 | -16.4% | 0.00% | – |
| Q2 2017 | $18,000 | -21.7% | 21,285 | -11.7% | 0.00% | – |
| Q1 2017 | $23,000 | +43.8% | 24,117 | +35.5% | 0.00% | – |
| Q4 2016 | $16,000 | -23.8% | 17,800 | -5.3% | 0.00% | – |
| Q3 2016 | $21,000 | +50.0% | 18,793 | +5.6% | 0.00% | – |
| Q2 2016 | $14,000 | -22.2% | 17,800 | 0.0% | 0.00% | – |
| Q1 2016 | $18,000 | -21.7% | 17,800 | 0.0% | 0.00% | – |
| Q4 2015 | $23,000 | -23.3% | 17,800 | -10.2% | 0.00% | – |
| Q3 2015 | $30,000 | -36.2% | 19,824 | +11.4% | 0.00% | – |
| Q2 2015 | $47,000 | +23.7% | 17,800 | 0.0% | 0.00% | – |
| Q1 2015 | $38,000 | +31.0% | 17,800 | 0.0% | 0.00% | – |
| Q4 2014 | $29,000 | +7.4% | 17,800 | 0.0% | 0.00% | – |
| Q3 2014 | $27,000 | -63.5% | 17,800 | -50.0% | 0.00% | – |
| Q2 2014 | $74,000 | +85.0% | 35,600 | +100.0% | 0.00% | – |
| Q1 2014 | $40,000 | -20.0% | 17,800 | 0.0% | 0.00% | – |
| Q4 2013 | $50,000 | -35.9% | 17,800 | -50.0% | 0.00% | – |
| Q3 2013 | $78,000 | +169.0% | 35,600 | +100.0% | 0.00% | – |
| Q2 2013 | $29,000 | – | 17,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,501,000 | $2,432,000 | 0.47% |
| Senvest Management, LLC | 2,278,995 | $3,692,000 | 0.26% |
| Opaleye Management Inc. | 250,000 | $405,000 | 0.20% |
| SABBY MANAGEMENT, LLC | 928,758 | $1,505,000 | 0.05% |
| Benchmark Capital Advisors | 40,000 | $65,000 | 0.04% |
| Orbimed Advisors | 1,135,000 | $1,839,000 | 0.02% |
| NEXT Financial Group, Inc | 28,500 | $46,000 | 0.02% |
| Cutter & CO Brokerage, Inc. | 10,000 | $16,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 110 | $0 | 0.00% |
| Renaissance Technologies | 26,878 | $44,000 | 0.00% |